On 2026-03-16, Zenas BioPharma, Inc. (ZBIO) announced earnings per share of $-4.54 for the fiscal quarter ending 2025-12-31, missing the average analyst estimate of $-1.22.
The next expected annoucement date for quarterly earnings is 2026-05-21, with an average estimated earnings per share of $-1.35 for the fiscal quarter ending 2026-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-03-16 | 2025-12-31 | $-1.22 | $-4.54 |
| 2025-11-12 | 2025-09-30 | $-0.87 | $-1.22 |
| 2025-08-12 | 2025-06-30 | $-1.02 | $-1.25 |
| 2025-05-15 | 2025-03-31 | $-1.15 | $-0.80 |
| 2024-11-12 | 2024-09-30 | $-13.00 | $-5.02 |